高血压病红／白细胞变形性的研究

本文观察了52例原发性高血压和24例正常人的红细胞、白细胞变形性,红细胞膜钙泵、钠泵活性,血粘度及血浆粘度,结果发现:原发性高血压组高、中切变率血粘度和钠泵活性显著高于正常组,红细胞变形性和钙泵活性显著高于正常组;红细胞变形性和钙泵活性显著低于正常组.白细胞变形性、低切变率血粘度及血浆粘度与正常组比较无显著差别.原发性高血压组红细胞变形性与年龄、平均动脉压、钙泵活性,高、中切变率血粘度相关.心痛定和川芎嗪治疗后,红细胞变形性显著改善,川芎嗪还能降低高切变率血粘度.结果提示:在高血压病中红细胞变形性降低、血粘度增高的分子水平机制主要是红细胞膜钙泵活性降低。基于微循环的改善,在扩大治疗例数后,心痛定和川芎嗪可能作为降压治疗的优选药与辅助药。     

内毒素分子结构与肠源性感染

研究表明,内毒素在肠源性感染发病中起重要作用。本文旨在观察内毒素分子结构中的不同组分与肠源性感染的关系。结果示内毒素分子结构中核心多糖链的终末片段的沙门氏菌内毒素(wildtype)及内毒素Ra和Rb造成肠源性感染的发病率分别为54％,83％和92％;而缺乏多糖链终末片断的内毒素Rc,Rd和Re及类脂A均末能造成肠源性感染。核心多糖链的终末片段是内毒素造成肠源性感染的分子学基础。     

大鼠失血性休克后肠道微生态的改变

本研究对无特殊致病菌大鼠失血性休克后肠道微生态的改变及肠道细菌易位进行了动态观察。结果表明,失血性休克复苏后5小时,肠道微生态即发生改变,表现为回肠内肠杆菌菌量增多,肠道内类杆菌与肠杆菌菌量比值下降,而后这一改变随时间推移逐渐恢复;肠道细菌易位率也有类似变化,易位细菌以肠杆菌为主。结果提示,大鼠失血性休克后肠道细菌易位与肠道微生态的改变有密切关系。     

二氧化碳噬纤维菌在牙周炎、牙龈炎患者及健康人口腔中分布的研究

为了解Capno菌与牙周病的关系,本实验分别对25例成人牙周炎、17例牙龈炎患者以及153名健康人(36名儿童,34名青年,49名老年人及34名与牙周病患者对照研究的健康成人)的龈上菌斑、龈下菌斑和唾液标本中的Capno菌的检出结果进行了统计学分析。研究表明:Capno菌在牙周炎、牙龈炎患者及健康人的菌斑及唾液中的检出率无差异(P>0.05),认为该菌是口腔的正常菌群之一。Capno在健康人菌斑中的检出率以儿童、青年为高,可能是青少年口腔中的优势菌群之一。     

电离辐射降低大鼠胰淀粉酶和胰蛋白酶活性机制的一些初步分析

1.丙线照射后胰淀粉酶、胰蛋白酶活性明显降低,胰酶活性降低程度和胰腺重量有关。在一定照射剂量范围内,胰酶活性和腺重量随着照射剂量的增加而下降。2.同样剂量的丙线照射后,胰腺组织匀浆上清液中的胰酶活性无变化。3.丙线照射后胰腺腺泡由M受体激动剂氨甲酰胆碱引起的淀粉酶分泌量明显减少。4.电镜观察表明,丙线照射后大鼠胰腺腺泡内合成及分泌酶原的内质网、线粒体等超微结构紊乱,这可能是电离辐射后胰酶活性降低的主要原因。     

马鞍菌属新种和新记录Ⅱ.

本文报道了近年来在中国发现的马鞍菌属 Heluella 的3个新种,即蛟河马鞍菌H.Jiaohensis,吉林马鞍菌 H.jilinensis 和新疆马鞍菌 H.xinjiangensis;3个新记录种即肋盖马鞍菌 H.costifera,长孢马鞍菌 H.oblongispora 和灰黑马鞍菌 H.rivularis。此外由于亚梭孢马鞍菌 H.subfusispora 的模式标本于1984年在火中被毁,因此作者在另一份标本(HMAS 30483)的基础上为其标定了新模式(Neotype)。     

Influence of new hydroxylated triphenylethylene (TPE) derivatives on estradiol binding to uterine cytosol

Twelve homologous triphenyl acrylonitrile derivatives with a p-OH or p-CH3 group on one or more of the phenyl rings were synthesized in order to assess the relative influence of each position on binding to the estrogen receptor (ER) and on inhibition of prostaglandin synthetase (PGS). Their relative binding affinities (RBAs) for [3H]estradiol (E2)-labeled ER were compared at 0 and 25 degrees C in mouse and rat uterus cytosol with those of tamoxifen derivatives, cyclofenil and diethylstilbestrol. RBAs in both species were closely correlated (r = 0.92) although the RBAs were about twice as high in the mouse as in the rat. The unsubstituted skeleton had an RBA of much less than 0.1 (estradiol = 100). An OH-group in R1 or R2 (Fig. 1) engendered very low affinity whereas an OH-group in R gave rise to a compound with an RBA equivalent to that of E2, emphasizing the importance of this position in the interaction with ER. Compounds with an additional OH-group in R1 or R2 were significantly better competitors than E2. No further increase in RBA was noted with the trihydroxy derivative. The effect of the introduction of a hydrophobic CH3-group decreased affinity as expected in R, but also in position R1 unless a second OH-group was present in R2. None of the 12 test-compounds competed significantly for binding to the "anti-estrogen binding site" in rat kidney supernatant. Although polar groups were not necessary for inhibition of PGS, inhibition was enhanced by the presence of a hydroxy group in R or R1 (but not R2). Even greater inhibition was obtained by the further introduction of a CH3-group in R1 or R respectively. The conformations of these derivatives are compared to those of known estrogen ligands and anti-inflammatory agents in order to obtain further information on these protein recognition sites.     

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

Background

Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and implementation of a risk score model for CKD would allow comparison of the risks and benefits of adding potentially nephrotoxic antiretrovirals to a treatment regimen and would identify those at greatest risk of CKD. The aims of this study were to develop a simple, externally validated, and widely applicable long-term risk score model for CKD in HIV-positive individuals that can guide decision making in clinical practice.

Methods and Findings

A total of 17,954 HIV-positive individuals from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study with ≥3 estimated glomerular filtration rate (eGFR) values after 1 January 2004 were included. Baseline was defined as the first eGFR > 60 ml/min/1.73 m2 after 1 January 2004; individuals with exposure to tenofovir, atazanavir, atazanavir/ritonavir, lopinavir/ritonavir, other boosted protease inhibitors before baseline were excluded. CKD was defined as confirmed (>3 mo apart) eGFR ≤ 60 ml/min/1.73 m². Poisson regression was used to develop a risk score, externally validated on two independent cohorts.In the D:A:D study, 641 individuals developed CKD during 103,185 person-years of follow-up (PYFU; incidence 6.2/1,000 PYFU, 95% CI 5.7–6.7; median follow-up 6.1 y, range 0.3–9.1 y). Older age, intravenous drug use, hepatitis C coinfection, lower baseline eGFR, female gender, lower CD4 count nadir, hypertension, diabetes, and cardiovascular disease (CVD) predicted CKD. The adjusted incidence rate ratios of these nine categorical variables were scaled and summed to create the risk score. The median risk score at baseline was −2 (interquartile range –4 to 2). There was a 1:393 chance of developing CKD in the next 5 y in the low risk group (risk score < 0, 33 events), rising to 1:47 and 1:6 in the medium (risk score 0–4, 103 events) and high risk groups (risk score ≥ 5, 505 events), respectively. Number needed to harm (NNTH) at 5 y when starting unboosted atazanavir or lopinavir/ritonavir among those with a low risk score was 1,702 (95% CI 1,166–3,367); NNTH was 202 (95% CI 159–278) and 21 (95% CI 19–23), respectively, for those with a medium and high risk score. NNTH was 739 (95% CI 506–1462), 88 (95% CI 69–121), and 9 (95% CI 8–10) for those with a low, medium, and high risk score, respectively, starting tenofovir, atazanavir/ritonavir, or another boosted protease inhibitor.The Royal Free Hospital Clinic Cohort included 2,548 individuals, of whom 94 individuals developed CKD (3.7%) during 18,376 PYFU (median follow-up 7.4 y, range 0.3–12.7 y). Of 2,013 individuals included from the SMART/ESPRIT control arms, 32 individuals developed CKD (1.6%) during 8,452 PYFU (median follow-up 4.1 y, range 0.6–8.1 y). External validation showed that the risk score predicted well in these cohorts. Limitations of this study included limited data on race and no information on proteinuria.

Conclusions

Both traditional and HIV-related risk factors were predictive of CKD. These factors were used to develop a risk score for CKD in HIV infection, externally validated, that has direct clinical relevance for patients and clinicians to weigh the benefits of certain antiretrovirals against the risk of CKD and to identify those at greatest risk of CKD.     

The hitchhiking effect of an autosomal meiotic drive gene

Transmission-ratio distortion is a departure from a 1:1 segregation of alleles in the gametes of a heterozygous individual. The so-called driving allele is strongly selected regardless of its effect on the fitness of the carrying individual. It may then have an important impact on neutral polymorphism due to the genetic hitchhiking effect. We study this hitchhiking effect in the case of true meiotic drive in autosomes and show that it is more dependent on the recombination rate than in the classical case of a gene positively selected at the organism level.     

空气流动增加压力型整体体积描记箱内压力变化的空气动力学研究

动物实验中,计算小动物呼吸容量如潮气量时通常遵循Boyle定律。而小动物在压力型体积描记箱内呼吸时,箱内气体处于不停的流动状态。为了研究气体流动本身对描记箱内压力是否产生影响,本研究采用空气动力学理论推导出压力型体积描记箱内压力变化的近似公式,并设计了三个实验对理论公式进行证明。首先,往体积描记箱内注入0.1mL、0.2mL和0.4mL空气,结果显示,描记箱内压力迅速上升至一峰值然后下降为一水平的基线压力值。3种容量的空气注入产生的压力变化最大值(峰压)及压力保持平稳时的压力变化值(基线压)分别为:(0.828±0.004)cmH2O、(0.684±0.003)cmH2O;(1.650±0.010)cmH2O、(1.350±0.007)cmH2O;(3.280±0.014)cmH2O、(2.658±0.011)cmH2O,峰压均显著高于基线压。其次,往体积描记箱内注入相同容量、但通气频率不同的空气,结果显示,随着注入空气的频率增加,描记箱内压力变化幅度亦显著增加。最后,用小动物呼吸机和微量移液器分别往描记箱内注入相同容量、相同频率但流量-时间函数不同的气体,结果显示,呼吸机引起的体积描记箱内峰压及基线压均显著高于微量移液器。以上结果表明,空气流动本身在压力型体积描记箱内引起压力变化;空气流动越快,压力变化幅度也越大;流动空气的流量是时间的不同函数时,压力变化也将显著不同。因此要精确地计算小动物呼吸容量变化,需要使用更多的空气动力学原理。